|
|
 |
|
 |
October 13, 2005
MDX Medical Inc: Granting Of Incentive Stock Options
Vancouver, BC - (October 13, 2005) MDX Medical Inc. (TSX.V: MDX) today announced, pursuant to the requirements of the TSX Venture Exchange, the granting of 1,790,000 incentive stock options to its directors, officers, and employees. The options allow the holder to purchase common shares of MDX at a price of $0.12 per share for a period of five years under the Stock Option Plan. The granting of these options is subject to acceptance for filing by the TSX Venture Exchange.
About MDX Medical
MDX Medical Inc.'s focus is on the commercialization of novel, innovative and leading edge medical device technologies for improved diagnosis and treatment of prominent health disorders. The Company�s business strategy is to acquire and commercialize high potential technologies that have reached the �proof of feasibility� or later stages of product development. For more information about MDX, please visit our website at: www.mdxmedical.com.
On behalf of the Board,
"Barry Allen"
President & CEO
MDX Medical Inc.
Certain information contained in this press release may be forward looking and is subject to unknown risks, which could cause actual results to differ materially from those, set forth or implied herein. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, it can give no assurance that such expectations will prove correct.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Barry Allen
Email: ballen@urodynamix.com |
|  |
|
